Who
Lance Berberian
Director
Company insider
Files Form 4 as: Director, Privia Health Group; EVP, Special Advisor, Strategy, Labcorp Holdings.
In numbers
- Trades disclosed
- 166
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $5.3M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 11 Mar 2015
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —8,463 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —8,463 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —7,668 at $0.00 | filing |
| 27 Mar 2025filed 31 Mar 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —3,325 at $0.00 | filing |
| 27 Mar 2025filed 31 Mar 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $313K1,353 at $231.67 | filing |
| 11 Feb 2025filed 13 Feb 2025 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —323 at $0.00 | filing |
| 11 Feb 2025filed 13 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —323 | filing |
| 11 Feb 2025filed 13 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $21K86 at $245.14 | filing |
| 7 Feb 2025filed 10 Feb 2025 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —354 at $0.00 | filing |
| 7 Feb 2025filed 10 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —354 | filing |
| 7 Feb 2025filed 10 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $23K94 at $246.27 | filing |
| 6 Feb 2025filed 10 Feb 2025 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —356 at $0.00 | filing |
| 6 Feb 2025filed 10 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —356 | filing |
| 6 Feb 2025filed 10 Feb 2025 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $23K94 at $247.74 | filing |
| 5 Aug 2024filed 7 Aug 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $516K2,245 at $229.79 | filing |
| 5 Aug 2024filed 7 Aug 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $2.3M9,848 at $228.95 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,697 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —7,697 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $714K3,299 at $216.57 | filing |
| 12 Feb 2024filed 13 Feb 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $20K87 at $227.45 | filing |
News
Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Lance Berberian; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.